Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

NCT04249401 ·Status: COMPLETED

DOAC in Unusual Site Venous Thrombosis

NCT03778502 ·Status: COMPLETED

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

NCT05750680 ·Status: ACTIVE_NOT_RECRUITING

Pilot Study: Comparison of Patients' Knowledge of Direct Oral Anticoagulants in Post-hospitalization Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview During Hospitalization

NCT04674202 ·Status: UNKNOWN

Periprocedural Direct Oral Anticoagulant Management

NCT03182218 ·Status: COMPLETED

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

Direct Oral Anticoagulants and Venous Thromboembolism

NCT02833987 ·Status: COMPLETED

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

NCT05038228 ·Status: ACTIVE_NOT_RECRUITING

Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications

NCT00528671 ·Status: TERMINATED ·Phase: PHASE4

Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis

NCT05705076 ·Status: UNKNOWN ·Phase: NA

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

NCT00806624 ·Status: COMPLETED ·Phase: PHASE2

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

NCT03572972 ·Status: COMPLETED

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

NCT06371170 ·Status: RECRUITING

LEAVE Safe With DOACs

NCT04068727 ·Status: COMPLETED ·Phase: NA

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

NCT05825573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

NCT02470767 ·Status: COMPLETED

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

NCT01210755 ·Status: COMPLETED ·Phase: PHASE4

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

NCT01619007 ·Status: COMPLETED

Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

NCT02448901 ·Status: UNKNOWN

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement

NCT03284827 ·Status: COMPLETED ·Phase: PHASE4

Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagulants Compared to Non-anticoagulated Patients

NCT07019077 ·Status: RECRUITING

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

NCT05627375 ·Status: RECRUITING ·Phase: PHASE3

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

NCT02468102 ·Status: COMPLETED